|
|
Article: NicOx and Biolipox Expand Research Collaboration on Novel Nitric Oxide-Donating Compounds for the Treatment of Respiratory Diseases.
- Article from:
- PR Newswire
- Article date:
- January 29, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NicOx SA (Nouveau Marche: NICOX) announces today the expansion of its research and co-development agreement with the Swedish pharmaceutical research-based company Biolipox on a novel class of nitric oxide-donating therapeutics in the respiratory field, originally signed in June 2001.
The collaboration combines NicOx's intellectual property and know-how in the nitric oxide field with Biolipox's expertise in the characterization of mechanisms and screening of compounds for the treatment of airway diseases in order to identify novel drug candidates. NicOx will synthesize a series of patented new compounds for pre-clinical evaluation by Biolipox. Compounds ...